GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BUE:ABBV) » Definitions » Shiller PE Ratio

AbbVie (BUE:ABBV) Shiller PE Ratio : 42.74 (As of May. 06, 2025)


View and export this data going back to 2021. Start your Free Trial

What is AbbVie Shiller PE Ratio?

As of today (2025-05-06), AbbVie's current share price is ARS23825.00. AbbVie's E10 for the quarter that ended in Dec. 2024 was ARS557.49. AbbVie's Shiller PE Ratio for today is 42.74.

The historical rank and industry rank for AbbVie's Shiller PE Ratio or its related term are showing as below:

BUE:ABBV' s Shiller PE Ratio Range Over the Past 10 Years
Min: 24.95   Med: 33.97   Max: 45.21
Current: 41.84

During the past years, AbbVie's highest Shiller PE Ratio was 45.21. The lowest was 24.95. And the median was 33.97.

BUE:ABBV's Shiller PE Ratio is ranked worse than
76.91% of 524 companies
in the Drug Manufacturers industry
Industry Median: 24.18 vs BUE:ABBV: 41.84

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AbbVie's adjusted earnings per share data for the three months ended in Dec. 2024 was ARS-20.200. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ARS557.49 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AbbVie Shiller PE Ratio Historical Data

The historical data trend for AbbVie's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Shiller PE Ratio Chart

AbbVie Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.44 34.42 36.48 34.31 37.46

AbbVie Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.63 37.21 42.26 37.46 -

Competitive Comparison of AbbVie's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, AbbVie's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Shiller PE Ratio falls into.


;
;

AbbVie Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AbbVie's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=23825.00/557.49
=42.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, AbbVie's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-20.2/133.1571*133.1571
=-20.200

Current CPI (Dec. 2024) = 133.1571.

AbbVie Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 5.556 99.621 7.426
201506 7.542 100.684 9.974
201509 6.958 100.392 9.229
201512 11.908 99.792 15.889
201603 12.121 100.470 16.064
201606 13.700 101.688 17.940
201609 14.469 101.861 18.915
201612 13.475 101.863 17.615
201703 16.342 102.862 21.155
201706 19.621 103.349 25.280
201709 17.699 104.136 22.632
201712 0.573 104.011 0.734
201803 35.059 105.290 44.338
201806 31.424 106.317 39.357
201809 66.606 106.507 83.272
201812 -46.557 105.998 -58.486
201903 64.498 107.251 80.078
201906 21.893 108.070 26.975
201909 70.467 108.329 86.617
201912 112.374 108.420 138.013
202003 125.380 108.902 153.306
202006 -31.492 108.767 -38.554
202009 95.770 109.815 116.127
202012 0.814 109.897 0.986
202103 179.259 111.754 213.590
202106 39.787 114.631 46.217
202109 174.048 115.734 200.249
202112 228.237 117.630 258.365
202203 269.504 121.301 295.846
202206 61.368 125.017 65.364
202209 307.079 125.227 326.526
202212 231.357 125.222 246.018
202303 25.682 127.348 26.854
202306 273.600 128.729 283.012
202309 349.950 129.860 358.836
202312 166.060 129.419 170.856
202403 648.725 131.776 655.523
202406 689.535 132.554 692.673
202409 836.440 133.029 837.246
202412 -20.200 133.157 -20.200

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AbbVie  (BUE:ABBV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AbbVie Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AbbVie's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie Business Description

Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).